The following are key perspectives from the 2019 American College of Cardiology/American Heart Association (ACC/AHA) Guideline on the Primary Prevention of Cardiovascular Disease (CVD): Scope of Guideline. Potential barriers to adhering to a heart-healthy diet should be assessed, including food access and economic factors; these factors may be particularly relevant to persons from vulnerable populations, such as individuals residing in either inner- city or rural environments, those at socioeconomic disadvantage, and those of advanced age*. Arnett et al 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease e598 September 10, 2019 Circulation. The focus is on medical practice in the United States, but these guidelines are relevant to patients throughout the world. Clinical Practice Guidelines 2019 Condition 2019 Guidelines Preventive Health Preventive health guidelines developed by HPSJ Health Educator - has been approved by committee NEW ITEM Smoking Cessation Adding Smoking Cessation Practice Guidelines 2. J Am Coll Cardiol. 2019;140:e596–e646. (31)School of Medicine, University of Cyprus, Nicosia, Cyprus. - The 2019 expert consensus was that canagliflozin and dapagliflozin should also be Page 4 of 98 . Yancy CW, Jessup M, Bozkurt B, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 1267 Congestive Heart Failure Clinical Practice Guideline Page 3 of 6 The quality of life for members who have CHF can be greatly improved through increased knowledge about congestive heart failure and through developing an action plan for managing care, based off best practice guidelines. ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary Endorsed by the American Association of Cardiovascular and Pulmonary ... heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. DOI: 10.1161/CIR.0000000000000678 CIICA SAS AD GIDIS cardiovascular disease (CVD). In the March 9 issue of The Lancet we publish a Series of three reviews on heart failure. The aim is to provide up-to-date information and authors’ personal assessments of pharmaceutical approaches to the treatment of heart failure, the use of devices and cellular approaches to treatment, and a pathway for the use of imaging techniques in the diagnosis of heart failure. (30)Heart Failure Unit, Attikon University Hospital, National and Kapodistrian University of Athens, Greece. b) Clinical signs of heart failure including JVD, pulmonary congestion, hepatojugular reflux, S3 gallop, laterally displaced PMI, ascites, or edema. What is heart failure? 2017;70:776-803. HF is a clinical syndrome with symptoms (usually dyspnoea) and signs secondary to 2. Access ACC guidelines and clinical policy documents as well as related resources The sodium-glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering therapies that have been shown to reduce risks of heart failure (HF) events in patients with type 2 diabetes mellitus (T2DM) at high-risk for or with cardiovascular disease. 2 NATIONAL HEART FAILURE AUDIT 2019 Summary Report (2017/18 data) 1.3 GUIDELINES AND QUALITY STANDARDS The NHFA dataset is continuously evolving to ensure it remains an effective representation of current evidence-based guideline